RSV wasn’t as hard on U.S. babies last winter. This may be why
Last winter’s respiratory syncytial virus, or RSV, season wasn’t as brutal for U.S. babies. A new study suggests two preventive tools — a maternal vaccine and a monoclonal antibody for infants — may have helped. The 2024-25 RSV season was the first in which the vaccine and the monoclonal antibody, which can prevent severe RSV…
